LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Recommendation of “Buy” from Brokerages

LeMaitre Vascular, Inc. (NASDAQ:LMAT) has been given an average rating of “Buy” by the eight research firms that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a hold recommendation, six have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $94.57.

A number of equities analysts have weighed in on the stock. Oppenheimer reiterated an “outperform” rating and issued a $93.00 price target (up from $90.00) on shares of LeMaitre Vascular in a research report on Friday, November 1st. Barrington Research boosted their price objective on LeMaitre Vascular from $92.00 to $93.00 and gave the company an “outperform” rating in a research report on Friday, November 1st. Cantor Fitzgerald assumed coverage on LeMaitre Vascular in a research report on Tuesday, October 15th. They set a “neutral” rating and a $96.00 target price for the company. Finally, StockNews.com cut LeMaitre Vascular from a “buy” rating to a “hold” rating in a report on Friday, December 13th.

LeMaitre Vascular Stock Up 0.5 %

LMAT stock opened at $98.44 on Tuesday. The business’s 50-day moving average price is $96.58 and its 200-day moving average price is $93.28. The stock has a market cap of $2.21 billion, a P/E ratio of 53.79, a PEG ratio of 2.19 and a beta of 0.96. LeMaitre Vascular has a twelve month low of $58.66 and a twelve month high of $109.58.

Insiders Place Their Bets

In other news, Director Bridget A. Ross sold 3,750 shares of the business’s stock in a transaction dated Friday, November 15th. The shares were sold at an average price of $101.47, for a total value of $380,512.50. Following the sale, the director now directly owns 2,278 shares in the company, valued at $231,148.66. The trade was a 62.21 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 10.79% of the company’s stock.

Institutional Investors Weigh In On LeMaitre Vascular

Large investors have recently added to or reduced their stakes in the stock. Envestnet Portfolio Solutions Inc. boosted its stake in shares of LeMaitre Vascular by 10.1% during the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 3,440 shares of the medical instruments supplier’s stock worth $317,000 after purchasing an additional 315 shares during the period. CBIZ Investment Advisory Services LLC grew its stake in shares of LeMaitre Vascular by 38.5% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 421 shares of the medical instruments supplier’s stock valued at $39,000 after buying an additional 117 shares during the last quarter. Swiss National Bank raised its holdings in shares of LeMaitre Vascular by 0.8% in the fourth quarter. Swiss National Bank now owns 39,800 shares of the medical instruments supplier’s stock worth $3,667,000 after buying an additional 300 shares during the period. HighTower Advisors LLC lifted its stake in shares of LeMaitre Vascular by 3.9% during the 4th quarter. HighTower Advisors LLC now owns 5,683 shares of the medical instruments supplier’s stock worth $524,000 after acquiring an additional 212 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in LeMaitre Vascular by 35.9% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,329 shares of the medical instruments supplier’s stock valued at $767,000 after acquiring an additional 2,200 shares during the period. 84.64% of the stock is owned by institutional investors.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.